MoneyWorks4Me

The sales slipped to Rs. 3562.40 millions for the March 2026 quarter as against Rs. 4612.40 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -153.90 millions as compared to Net Profit of Rs. 512.20 millions of corresponding quarter ended March 2025The company reported a degrowth in operating Profit to 347.10 millions from 810.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3562.40 4612.40 -22.76 14122.90 17357.00 -18.63 14122.90 17357.00 -18.63
Other Income 222.20 60.50 267.27 629.00 408.30 54.05 629.00 408.30 54.05
PBIDT 347.10 810.30 -57.16 1132.60 2947.10 -61.57 1132.60 2947.10 -61.57
Interest 40.90 15.30 167.32 118.00 76.20 54.86 118.00 76.20 54.86
PBDT 182.60 835.00 -78.13 3284.40 2910.90 12.83 3284.40 2910.90 12.83
Depreciation 289.70 274.70 5.46 1190.30 1084.10 9.80 1190.30 1084.10 9.80
PBT -107.10 560.30 -119.11 2094.10 1826.80 14.63 2094.10 1826.80 14.63
TAX 46.80 48.10 -2.70 504.70 197.20 155.93 504.70 197.20 155.93
Deferred Tax 46.80 48.10 -2.70 500.30 197.20 153.70 500.30 197.20 153.70
PAT -153.90 512.20 -130.05 1589.40 1629.60 -2.47 1589.40 1629.60 -2.47
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 9.74 17.57 -44.54 8.02 16.98 -52.77 8.02 16.98 -52.77
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..